We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$12.6B
AUM Growth
-$409M
(-3.1%)
Cap. Flow
-$304M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
25.36%
Holding
834
New
37
Increased
442
Reduced
281
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$88.6M |
| 2 |
B2Gold
BTG
|
+$55.1M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$39.3M |
| 4 |
SE
Spectra Energy Corp Wi
SE
|
+$38.9M |
| 5 |
Patterson-UTI
PTEN
|
+$37.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cummins
CMI
|
+$78.5M |
| 2 |
Franco-Nevada
FNV
|
+$57.5M |
| 3 |
Agnico Eagle Mines
AEM
|
+$54.9M |
| 4 |
Walt Disney
DIS
|
+$41.1M |
| 5 |
Applied Materials
AMAT
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 38.92% |
| 2 | Energy | 24.99% |
| 3 | Healthcare | 9.19% |
| 4 | Industrials | 4.38% |
| 5 | Technology | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Omnicom Group
OMC
$23.5B
| $123K | ﹤0.01% |
1,627
+503
| +45% | +$36.9K |
|
|
FOMX
602
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $123K | ﹤0.01% |
15,114
+2,213
| +17% | +$16.5K |
|
|
RDHL
603
Redhill Biopharma
RDHL
$4.15M
| $121K | ﹤0.01% |
9
+1
| +13% | +$12.4K |
|
|
FISV
604
Fiserv Inc
FISV
$29.7B
| $120K | ﹤0.01% |
+2,620
| New | +$123K |
|
|
GNMX
605
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $120K | ﹤0.01% |
19,868
+2,279
| +13% | +$15.5K |
|
606
Baxter International
BAX
$12.8B
| $118K | ﹤0.01% |
+3,080
| New | +$113K |
|
|
PARA
607
DELISTED
Paramount Global Class B
PARA
| $118K | ﹤0.01% |
2,507
+755
| +43% | +$35.4K |
|
|
NDRM
608
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $117K | ﹤0.01% |
6,879
-279
| -4% | -$5.43K |
|
|
ENZY
609
DELISTED
Enzymotec Ltd
ENZY
| $116K | ﹤0.01% |
11,884
-1,755
| -13% | -$16.6K |
|
610
Monster Beverage
MNST
$95.1B
| $114K | ﹤0.01% |
4,602
-90
| -2% | -$2.17K |
|
611
Canadian Pacific Kansas City
CP
$81B
| $113K | ﹤0.01% |
+4,440
| New | +$125K |
|
612
Keurig Dr Pepper
KDP
$42.8B
| $112K | ﹤0.01% |
1,203
+349
| +41% | +$31K |
|
613
PBF Energy
PBF
$7.49B
| $112K | ﹤0.01% |
3,055
+1,340
| +78% | +$47.2K |
|
614
Protalix BioTherapeutics
PLX
$183M
| $108K | ﹤0.01% |
10,621
+3,942
| +59% | +$40.1K |
|
|
CHMA
615
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $107K | ﹤0.01% |
+5,477
| New | +$119K |
|
616
Progressive
PGR
$128B
| $104K | ﹤0.01% |
3,269
+954
| +41% | +$30.3K |
|
617
Magna International
MGA
$18.8B
| $102K | ﹤0.01% |
2,517
+723
| +40% | +$33.7K |
|
|
STJ
618
DELISTED
St Jude Medical
STJ
| $102K | ﹤0.01% |
1,651
+531
| +47% | +$33.5K |
|
619
Edwards Lifesciences
EW
$49.4B
| $101K | ﹤0.01% |
3,840
+1,152
| +43% | +$29.9K |
|
620
Graphic Packaging
GPK
$3.35B
| $101K | ﹤0.01% |
7,884
+808
| +11% | +$10.9K |
|
|
CERN
621
DELISTED
Cerner Corp
CERN
| $101K | ﹤0.01% |
1,686
+443
| +36% | +$27.2K |
|
622
Chipotle Mexican Grill
CMG
$43.9B
| $100K | ﹤0.01% |
10,400
+3,100
| +42% | +$37.9K |
|
623
Kornit Digital
KRNT
$677M
| $100K | ﹤0.01% |
9,300
+616
| +7% | +$7.34K |
|
624
Hershey
HSY
$37.3B
| $99K | ﹤0.01% |
1,107
+351
| +46% | +$31.5K |
|
625
Petrobras
PBR
$120B
| $99K | ﹤0.01% |
22,932
+2,042
| +10% | +$9.94K |
|
Similar funds
DAM
VanEck Associates's Q4 2015 Portfolio in Review
As of Q4 2015, VanEck Associates held 834 positions worth $12.6B, down 3.1% from $13B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q4 2015 filing shows 37 new, 442 increased, 281 reduced and 71 closed positions. Its largest new stake was Kansas City Southern: 460,194 shares worth $34.4M. The largest sale was Cummins, an estimated $78.5M.
By sector, the portfolio is most concentrated in Materials at 39% of assets, down from 40% a quarter earlier, followed by Energy and Healthcare.
- VanEck Associates's largest Q4 2015 buy was Kansas City Southern: 460,194 shares worth $34.4M.
- VanEck Associates added most to CF Industries in Q4 2015, an estimated $88.6M increase.
- VanEck Associates's biggest Q4 2015 reduction was Cummins, cutting an estimated $78.5M.
- VanEck Associates fully exited Procter & Gamble in Q4 2015, selling an estimated $39.7M.
- VanEck Associates's ten largest holdings make up 25% of its $12.6B portfolio in Q4 2015.
- VanEck Associates opened 37 new positions and closed 71 in Q4 2015.
- VanEck Associates's portfolio value fell 3.1% quarter-over-quarter to $12.6B.
Based on VanEck Associates's 13F filing for Q4 2015, filed 12 Feb 2016.